by Coralie Carlson | Sep 20, 2024
The wealthy are thriving, but the stocks of the luxury stores that cater to them aren’t. And while lower-income shoppers feel the pinch, the stocks of the big box stores they shop at are booming. The dichotomy is one of the curve balls in the post-pandemic economy....
by Joseph V. Lingad | Oct 5, 2023
UnitedHealth–the country’s largest health insurer provider–is well-positioned to benefit from rising baby boomers signing up for federal-funded healthcare plans. Enrollment for Medicare Advantage, health coverage for people 65 or older, is expected to grow by...
by Mariam Kiparoidze | Sep 28, 2023
Even though Covid-19 cases and hospitalization numbers are up, they won’t be a shot in the arm for either Moderna or Pfizer stock. Pfizer (NYSE:PFE) closed at $32.69 per share, down by 36.2% year to date on September 22. Moderna (Nasdaq:MRNA) ended the week on a...
by Nicholas Morgan | Sep 25, 2023
Crypto-mining stocks were buoyed over the summer by developments that seemed to suggest that the crypto sector would be legitimized, but those hopes have been slow to materialize. Riot Platforms, the largest mining stock by market capitalization, fell 11% in value to...
by Caroline Handel | Sep 25, 2023
With dual Hollywood strikes stretching into the closing months of the year, investors are throwing their weight behind newer entrants into the entertainment sector, leaving legacy media companies behind. Since the industry shutdown, shares of old-guard entertainment...
by Divya Murthy | Sep 25, 2023
Despite new COVID variants spreading through the country, falling vaccine demand is prompting market-leading vaccine-makers Pfizer and Moderna to find their fortunes elsewhere. Since January, Pfizer’s stock has shed 36% and Moderna’s stock has shed 42% closing on...
